Mitsubishi UFJ Asset Management
BIO icon

Mitsubishi UFJ Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Mitsubishi UFJ Asset Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.7K Hold
50
– – ﹤0.01% 1386
2026
Q1 		$13.9K Hold
50
– – ﹤0.01% 1322
2025
Q4 		$15.3K Hold
50
– – ﹤0.01% 1286
2025
Q3 		$14K Hold
50
– – ﹤0.01% 1283
2025
Q2 		$12.1K Sell
50
-15,032
-100% -$3.55M ﹤0.01% 1300
2025
Q1 		$3.67M Hold
15,082
– – ﹤0.01% 674
2024
Q4 		$4.99M Hold
15,082
– – ﹤0.01% 655
2024
Q3 		$5.05M Sell
15,082
-12,142
-45% -$3.86M 0.01% 653
2024
Q2 		$7.44M Buy
27,224
+4,374
+19% +$1.27M 0.01% 587
2024
Q1 		$7.9M Buy
22,850
+2,113
+10% +$695K 0.01% 568
2023
Q4 		$6.61M Buy
20,737
+38
+0.2% +$11.9K 0.01% 558
2023
Q3 		$7.42M Buy
20,699
+1,497
+8% +$578K 0.02% 534
2023
Q2 		$7.28M Buy
19,202
+3,207
+20% +$1.31M 0.02% 533
2023
Q1 		$7.66M Buy
15,995
+52
+0.3% +$24.3K 0.02% 519
2022
Q4 		$6.73M Buy
15,943
+2,569
+19% +$1.04M 0.02% 519
2022
Q3 		$5.58M Buy
13,374
+701
+6% +$349K 0.02% 524
2022
Q2 		$6.27M Buy
12,673
+981
+8% +$511K 0.03% 509
2022
Q1 		$6.58M Buy
11,692
+1,605
+16% +$968K 0.03% 522
2021
Q4 		$7.42M Buy
10,087
+724
+8% +$542K 0.03% 509
2021
Q3 		$6.98M Buy
9,363
+1,255
+15% +$940K 0.03% 487
2021
Q2 		$5.22M Buy
8,108
+668
+9% +$407K 0.03% 545
2021
Q1 		$4.25M Buy
7,440
+898
+14% +$532K 0.03% 542
2020
Q4 		$3.81M Buy
6,542
+761
+13% +$433K 0.03% 514
2020
Q3 		$2.98M Buy
5,781
+748
+15% +$379K 0.03% 497
2020
Q2 		$2.27M Buy
5,033
+1,752
+53% +$773K 0.03% 507
2020
Q1 		$1.15M Sell
3,281
-123
-4% -$45.2K 0.02% 593
2019
Q4 		$1.25M Buy
+3,404
New +$1.2M 0.02% 651

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Mitsubishi UFJ Asset Management's BIO Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management held its Bio-Rad Laboratories Class A (BIO) position steady in Q2 2026 at 50 shares worth $14.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.

Mitsubishi UFJ Asset Management first reported a position in BIO in Q4 2019 and has held it in 27 quarters since. The position peaked at $7.9M in Q1 2024. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 50 shares of Bio-Rad Laboratories Class A worth $14.7K as of Q2 2026.
  • Mitsubishi UFJ Asset Management left its Bio-Rad Laboratories Class A share count unchanged in Q2 2026.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #1386 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and has held it in 27 quarters since.
  • Mitsubishi UFJ Asset Management's Bio-Rad Laboratories Class A position peaked at $7.9M in Q1 2024.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.